0001966649-26-000001.txt : 20260219 0001966649-26-000001.hdr.sgml : 20260219 20260218183116 ACCESSION NUMBER: 0001966649-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260219 DATE AS OF CHANGE: 20260218 EFFECTIVENESS DATE: 20260219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Akava Therapeutics Inc. CENTRAL INDEX KEY: 0001966649 ORGANIZATION NAME: EIN: 922337406 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-573943 FILM NUMBER: 26650768 BUSINESS ADDRESS: STREET 1: 755 SHERIDAN ROAD CITY: WINNETKA STATE: IL ZIP: 60093 BUSINESS PHONE: (847) 494-7434 MAIL ADDRESS: STREET 1: 755 SHERIDAN ROAD CITY: WINNETKA STATE: IL ZIP: 60093 D 1 primary_doc.xml X0708 D LIVE 0001966649 Akava Therapeutics Inc. 755 SHERIDAN ROAD WINNETKA IL ILLINOIS 60093 (847) 494-7434 DELAWARE Akava Therapeutics, LLC None Corporation true Richard Silverman 755 Sheridan Road Winnetka IL ILLINOIS 60093 Executive Officer Director Philip Silverman 3500 Munroe Drive Miami FL FLORIDA 33133 Executive Officer Director Brendan MacMillan 115 E Putnam Ave., 3rd Floor Greenwich CT CONNECTICUT 06830 Director Joseph Nolan 100 Park Lane Lake Bluff IL ILLINOIS 60044 Director Charles Polsky 191 N Wacker Drive, Suite 1500 Chicago IL ILLINOIS 60606 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false true false true true true false 100000 15000000 0 15000000 false 0 0 0 0 false Akava Therapeutics Inc. /s/ Philip Silverman Philip Silverman Secretary 2026-02-18